Cargando…
The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
Systemic treatment options for patients with lung cancer have expanded in recent years, with a number of immunotherapeutic strategies now in our treatment armamentarium. Toxicity of and resistance to treatment hold a major stake in lung cancer morbidity and mortality. Herein, we summarise the backgr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388426/ https://www.ncbi.nlm.nih.gov/pubmed/35876944 http://dx.doi.org/10.1007/s10555-022-10039-1 |